CA
RNVA

Commerzbank Aktiengesellschaft’s Rennova Health, Inc. RNVA Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio RNVA Stock Details RNVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-46
Closed -$15K – 1072
2016
Q1 		$15K Hold
46
– – ﹤0.01% 1018
2015
Q4 		$28K Buy
46
+25
+119% +$43.2K ﹤0.01% 1128
2015
Q3 		$64K Buy
+21
New +$57.2K ﹤0.01% 1082

Other funds holding RNVA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerzbank Aktiengesellschaft's RNVA Position: Q2 2016 in Review

Commerzbank Aktiengesellschaft sold out of Rennova Health, Inc. (RNVA) in Q2 2016, closing a stake of 46 shares — an estimated $15K sold.

Commerzbank Aktiengesellschaft first reported a position in RNVA in Q3 2015 and held it in 3 quarters. The position peaked at $64K in Q3 2015. 9 funds tracked by Wall St. Rank hold RNVA as of Q2 2016.

  • Commerzbank Aktiengesellschaft reported no remaining Rennova Health, Inc. position as of Q2 2016 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 46 Rennova Health, Inc. shares in Q2 2016, an estimated $15K.
  • Commerzbank Aktiengesellschaft first reported a position in Rennova Health, Inc. in Q3 2015 and held it in 3 quarters.
  • Commerzbank Aktiengesellschaft's Rennova Health, Inc. position peaked at $64K in Q3 2015.
  • 9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q2 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2016, filed 1 Aug 2016.